Weekly Update: New Drug Pricing Deals, Breakthroughs in Gene Therapy, and Major Pharma Deals
This week in pharmaceutical news brings important updates that could impact patients and healthcare providers. Here’s a breakdown in simple […]
This week in pharmaceutical news brings important updates that could impact patients and healthcare providers. Here’s a breakdown in simple […]
The U.S. Food and Drug Administration (FDA) has just approved a new medication called IMAAVY for a condition called warm
A new international pilot program is changing how global regulators and pharmaceutical companies manage changes to approved medicines after they
A potential new treatment for obesity, called HM17321, is being developed by Genentech (a part of the Roche Group) and
ViiV Healthcare has received approval from the U.S. Food and Drug Administration (FDA) for a new version of the HIV
A new medication called Daybu (trofinetide) has been approved in Europe for children aged five and older who have Rett
Eisai and Biogen have introduced a new form of the Alzheimer’s medication Leqembi called Leqembi Iqlik. This version comes as
A new guidance document from the UK’s medicines regulator, the MHRA, has laid out a clear path for companies to
A major breakthrough in cancer treatment has been approved by the U.S. Food and Drug Administration (FDA) for patients with
Pharmaceutical quality control labs are under increasing pressure to improve how they handle data to meet strict regulatory standards. Poor